Suppr超能文献

整合素在肿瘤血管生成与淋巴管生成中的作用

Integrins in tumor angiogenesis and lymphangiogenesis.

作者信息

Foubert Philippe, Varner Judith A

机构信息

Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA.

出版信息

Methods Mol Biol. 2012;757:471-86. doi: 10.1007/978-1-61779-166-6_27.

Abstract

Angiogenesis, the formation of new blood vessel, plays an important role for the growth and metastasis of malignant tumors. The recent identification of specific growth factors for lymphatic vessels and of new lymphatic-specific markers provided evidence for an active role of the lymphatic system during the tumor growth and metastasis processes. Tumor lymphangiogenesis has been shown to play a role in promoting tumor growth and metastasis of tumor cells to distant sites. Integrins play keys roles in the regulation of angiogenesis and lymphangiogenesis during normal development and several diseases. Indeed, integrins control vascular and lymphatic endothelial cell adhesion, migration, and survival. Importantly, integrin inhibitors can block angiogenesis and lymphangiogenesis. In this chapter, we will highlight the role of integrins during angiogenesis and lymphangiogenesis as well as the function of individual integrins during vascular development, postnatal angiogenesis, and lymphangiogenesis. We discuss the role of integrins as potential therapeutic targets for the control of tumor angiogenesis, lymphangiogenesis, and metastatic spread in the treatment of cancer. We also describe methods to analyze expression and function of integrins during angiogenesis and lymphangiogenesis.

摘要

血管生成,即新血管的形成,在恶性肿瘤的生长和转移过程中起着重要作用。最近对淋巴管特异性生长因子和新的淋巴管特异性标志物的鉴定,为淋巴系统在肿瘤生长和转移过程中的积极作用提供了证据。肿瘤淋巴管生成已被证明在促进肿瘤生长以及肿瘤细胞向远处转移中发挥作用。整合素在正常发育和多种疾病过程中,对血管生成和淋巴管生成的调节起着关键作用。事实上,整合素控制着血管和淋巴管内皮细胞的黏附、迁移及存活。重要的是,整合素抑制剂能够阻断血管生成和淋巴管生成。在本章中,我们将重点阐述整合素在血管生成和淋巴管生成过程中的作用,以及各个整合素在血管发育、出生后血管生成和淋巴管生成过程中的功能。我们将讨论整合素作为控制肿瘤血管生成、淋巴管生成及癌症治疗中转移扩散的潜在治疗靶点的作用。我们还将描述在血管生成和淋巴管生成过程中分析整合素表达和功能的方法。

相似文献

1
Integrins in tumor angiogenesis and lymphangiogenesis.
Methods Mol Biol. 2012;757:471-86. doi: 10.1007/978-1-61779-166-6_27.
2
Methods to study lymphatic vessel integrins.
Methods Enzymol. 2007;426:415-38. doi: 10.1016/S0076-6879(07)26018-5.
3
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
Lymphat Res Biol. 2008;6(3-4):155-63. doi: 10.1089/lrb.2008.1011.
4
Integrins in angiogenesis and lymphangiogenesis.
Nat Rev Cancer. 2008 Aug;8(8):604-17. doi: 10.1038/nrc2353. Epub 2008 May 22.
5
Modeling Proteolytically Driven Tumor Lymphangiogenesis.
Adv Exp Med Biol. 2016;936:107-136. doi: 10.1007/978-3-319-42023-3_6.
6
Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
Biochim Biophys Acta. 2004 Mar 4;1654(1):51-67. doi: 10.1016/j.bbcan.2003.09.003.
9
Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis.
J Biol Chem. 2007 May 18;282(20):15187-96. doi: 10.1074/jbc.M609323200. Epub 2007 Mar 14.
10
The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis.
Int J Mol Sci. 2020 Jul 21;21(14):5148. doi: 10.3390/ijms21145148.

引用本文的文献

1
MicroRNAs secreted by the parasitic nematode Brugia malayi disrupt lymphatic endothelial cell integrity.
PLoS Negl Trop Dis. 2024 Dec 31;18(12):e0012803. doi: 10.1371/journal.pntd.0012803. eCollection 2024 Dec.
3
Molecular Modeling Insights into the Structure and Behavior of Integrins: A Review.
Cells. 2023 Jan 14;12(2):324. doi: 10.3390/cells12020324.
4
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery.
Adv Drug Deliv Rev. 2023 Jan;192:114635. doi: 10.1016/j.addr.2022.114635. Epub 2022 Nov 26.
5
ITGA5 Promotes Tumor Progression through the Activation of the FAK/AKT Signaling Pathway in Human Gastric Cancer.
Oxid Med Cell Longev. 2022 Sep 24;2022:8611306. doi: 10.1155/2022/8611306. eCollection 2022.
6
Methyl Gallate Suppresses Tumor Development by Increasing Activation of Caspase3 and Disrupting Tumor Angiogenesis in Melanoma.
Evid Based Complement Alternat Med. 2022 Sep 6;2022:6295910. doi: 10.1155/2022/6295910. eCollection 2022.
7
Synthetic hydrogels engineered to promote collecting lymphatic vessel sprouting.
Biomaterials. 2022 May;284:121483. doi: 10.1016/j.biomaterials.2022.121483. Epub 2022 Mar 29.
9
Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
BMC Cancer. 2021 Dec 7;21(1):1312. doi: 10.1186/s12885-021-08987-y.
10
Improved Immunotherapy Efficacy by Vascular Modulation.
Cancers (Basel). 2021 Oct 17;13(20):5207. doi: 10.3390/cancers13205207.

本文引用的文献

1
alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.
Am J Pathol. 2009 Jun;174(6):2378-87. doi: 10.2353/ajpath.2009.080942. Epub 2009 May 14.
2
Novel agents on the horizon for cancer therapy.
CA Cancer J Clin. 2009 Mar-Apr;59(2):111-37. doi: 10.3322/caac.20003.
3
Regulation of angiogenesis: apoptotic cues from the ECM.
Oncogene. 2008 Oct 20;27(48):6285-98. doi: 10.1038/onc.2008.304.
4
Integrins: the keys to unlocking angiogenesis.
Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1703-13. doi: 10.1161/ATVBAHA.108.172015. Epub 2008 Jul 24.
5
Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice.
Cancer Res. 2007 Dec 15;67(24):11528-35. doi: 10.1158/0008-5472.CAN-07-1458.
6
Methods to study lymphatic vessel integrins.
Methods Enzymol. 2007;426:415-38. doi: 10.1016/S0076-6879(07)26018-5.
8
Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade.
Am J Pathol. 2007 Jul;171(1):361-72. doi: 10.2353/ajpath.2007.060896.
9
Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas.
BMC Cancer. 2007 Jun 21;7:105. doi: 10.1186/1471-2407-7-105.
10
Integrin inhibitors reaching the clinic.
J Clin Oncol. 2007 May 1;25(13):1637-8. doi: 10.1200/JCO.2006.09.8376.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验